Journal article · 2016

Abstract P1-10-20: Importance of the patient voice in drug development: Early-stage breast cancer and measurement gaps concerning the treatment experience

JA Petersen, MA Gauthier, Elisabeth Carine Piault, Kendra P.A. DeBusk, Joanne S. Buzaglo, Jennifer Eng‐Wong, JR Glazer, MC Green, Johnson Jm, Patricia A. Spears, CJ Evans

Cancer Research, 76(4_Supplement), P1–10 · Published 15 February 2016 · DOI 10.1158/1538-7445.sabcs15-p1-10-20

View at the publisherCite this paper

In brief

“Abstract P1-10-20: Importance of the patient voice in drug development: Early-stage breast cancer and measurement gaps concerning the treatment experience” is a 2016 journal article by JA Petersen and 10 co-authors, published in Cancer Research. OpenAlex counts 4 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
4
Most cited in
2025 (2)
Authors
11

Abstract

Background: Most early-stage breast cancer (EBC) patients (pts) do not experience signs or symptoms of disease; approximately 90% of women diagnosed in breast screening are asymptomatic in the US (Ryerson et al. 2015). Rather, side effects of cancer therapy have the greatest impact and can be burdensome to pts on and after treatment. Bother and… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Petersen, J., Gauthier, M., Piault, E. C., DeBusk, K. P., Buzaglo, J. S., Eng‐Wong, J., Glazer, J., Green, M., Jm, J., Spears, P. A., & Evans, C. (2016). Abstract P1-10-20: Importance of the patient voice in drug development: Early-stage breast cancer and measurement gaps concerning the treatment experience. Cancer Research, 76(4_Supplement), P1–10. https://doi.org/10.1158/1538-7445.sabcs15-p1-10-20

MLA 9

Petersen, JA, et al. “Abstract P1-10-20: Importance of the patient voice in drug development: Early-stage breast cancer and measurement gaps concerning the treatment experience.” Cancer Research, vol. 76, no. 4_Supplement, 2016, pp. P1–10. https://doi.org/10.1158/1538-7445.sabcs15-p1-10-20.

Chicago

Petersen, JA, MA Gauthier, Elisabeth Carine Piault, Kendra P.A. DeBusk, Joanne S. Buzaglo, Jennifer Eng‐Wong, JR Glazer, et al. 2016. “Abstract P1-10-20: Importance of the patient voice in drug development: Early-stage breast cancer and measurement gaps concerning the treatment experience.” Cancer Research 76 (4_Supplement): P1–10. https://doi.org/10.1158/1538-7445.sabcs15-p1-10-20.

Harvard

Petersen, J. et al. (2016) ‘Abstract P1-10-20: Importance of the patient voice in drug development: Early-stage breast cancer and measurement gaps concerning the treatment experience’, Cancer Research, 76(4_Supplement), pp. P1–10. doi:10.1158/1538-7445.sabcs15-p1-10-20.

IEEE

J. Petersen et al., “Abstract P1-10-20: Importance of the patient voice in drug development: Early-stage breast cancer and measurement gaps concerning the treatment experience,” Cancer Research, vol. 76, no. 4_Supplement, pp. P1–10, 2016, doi: 10.1158/1538-7445.sabcs15-p1-10-20.

BibTeX

@article{petersen2016abstract,
  title     = {{Abstract P1-10-20: Importance of the patient voice in drug development: Early-stage breast cancer and measurement gaps concerning the treatment experience}},
  author    = {Petersen, JA and Gauthier, MA and Piault, Elisabeth Carine and DeBusk, Kendra P.A. and Buzaglo, Joanne S. and Eng‐Wong, Jennifer and Glazer, JR and Green, MC and Jm, Johnson and Spears, Patricia A. and Evans, CJ},
  journal   = {Cancer Research},
  year      = {2016},
  volume    = {76},
  number    = {4_Supplement},
  pages     = {P1--10},
  doi       = {10.1158/1538-7445.sabcs15-p1-10-20},
  url       = {https://doi.org/10.1158/1538-7445.sabcs15-p1-10-20}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202211
202522
202611

Topic and keywords

Health Sciences › Medicine › Oncology › Cancer survivorship and care

  • early breast cancer
  • patient voice
  • patient-reported outcomes
  • treatment-related symptoms
  • treatment burden
  • adjuvant therapy
  • neoadjuvant therapy
  • chemotherapy

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Petersen, J., Gauthier, M., Piault, E. C., DeBusk, K. P., Buzaglo, J. S., Eng‐Wong, J., Glazer, J., Green, M., Jm, J., Spears, P. A., & Evans, C. (2016). Abstract P1-10-20: Importance of the patient voice in drug development: Early-stage breast cancer and measurement gaps concerning the treatment experience. Cancer Research, 76(4_Supplement), P1–10. https://doi.org/10.1158/1538-7445.sabcs15-p1-10-20

How many times has this paper been cited?

4 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

JA Petersen, MA Gauthier, Elisabeth Carine Piault, Kendra P.A. DeBusk, Joanne S. Buzaglo, Jennifer Eng‐Wong, JR Glazer, MC Green, Johnson Jm, Patricia A. Spears, CJ Evans.

What is the DOI of this paper?

10.1158/1538-7445.sabcs15-p1-10-20, permanently at https://doi.org/10.1158/1538-7445.sabcs15-p1-10-20. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.